Parametric Portfolio Associates’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-11,999
Closed -$467K 4028
2017
Q3
$467K Sell
11,999
-3,817
-24% -$140K ﹤0.01% 3459
2017
Q2
$473K Hold
15,816
﹤0.01% 3397
2017
Q1
$420K Sell
15,816
-7,273
-31% -$180K ﹤0.01% 3281
2016
Q4
$513K Hold
23,089
﹤0.01% 3180
2016
Q3
$427K Hold
23,089
﹤0.01% 3247
2016
Q2
$375K Hold
23,089
﹤0.01% 3350
2016
Q1
$326K Buy
+23,089
New +$312K ﹤0.01% 3561

Other funds holding NDRM

Parametric Portfolio Associates's NDRM Position: Q4 2017 in Review

Parametric Portfolio Associates sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2017, closing a stake of 11,999 shares — an estimated $467K sold.

Parametric Portfolio Associates first reported a position in NDRM in Q1 2016 and held it in 7 quarters. The position peaked at $513K in Q4 2016. 5 funds tracked by Wall St. Rank hold NDRM as of Q4 2017.

  • Parametric Portfolio Associates reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2017 after selling out during the quarter.
  • Parametric Portfolio Associates sold 11,999 NeuroDerm Ltd. Ordinary Shares shares in Q4 2017, an estimated $467K.
  • Parametric Portfolio Associates first reported a position in NeuroDerm Ltd. Ordinary Shares in Q1 2016 and held it in 7 quarters.
  • Parametric Portfolio Associates's NeuroDerm Ltd. Ordinary Shares position peaked at $513K in Q4 2016.
  • 5 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2017.

Based on Parametric Portfolio Associates's 13F filing for Q4 2017, filed 14 Feb 2018.